Open AccessAnticoagulant therapy with rivaroxaban in a young patient with paroxysmal nocturnal hemoglobinuria
Author(s) -
Dragoni Francesco,
Chiarotti Flavia,
Lombardi Laura,
Iori Anna Paola,
Cafolla Arturo
Publication year - 2015
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.342
Subject(s) - medicine , paroxysmal nocturnal hemoglobinuria , rivaroxaban , vitamin k antagonist , antithrombotic , anticoagulant therapy , anticoagulant , hemoglobinuria , oral anticoagulant , anemia , warfarin , atrial fibrillation
Key Clinical Message The new direct oral anticoagulants such us rivaroxaban, could play an important role in the anticoagulant treatment of patients with paroxysmal nocturnal hemoglobinuria where anticoagulant treatment is complex to run, since they have shown a reduction in serious bleeding complications compared to antithrombotic therapy with classical vitamin k antagonist.